|Researchers at Purdue University have developed a method of in vitro measurement of extracellular matrix (ECM) stiffness that is nondestructive and provides fast readout. ECM stiffness has recently been found to be a contributing factor in cancer or fibrotic disease development including cell differentiation and rapid cell multiplication. Current technologies used to measure ECM stiffness in vitro are often invasive and expensive as well as sometimes limited to detecting cell destruction only after detrimental cell deformations have already occurred. The approach fine-tuned by Purdue researchers includes a noninvasive on-chip platform that can characterize ECM stiffness with up to 93% accuracy. The efficiency and long term stability of this method was validated in various hydrogels with different stiffness levels. Additionally, in vitro cell culture tests showed a reasonable cell viability and survival rate under continuous exposure to an ultrasonic wave inside the platform. The highly selective, biocompatible sensors can also be implemented in applications including drug screening, drug discovery, and 3D cell cultures.
-3D Cell Cultures
-Therapeutic Efficacy Monitoring
The efficiency and long term stability of the ultrasonic stiffness measurement method was validated in various hydrogels with different stiffness levels. Additionally, in vitro cell culture tests showed a reasonable cell viability and survival rate under continuous exposure to an ultrasonic wave inside the platform.
A Lab-on-Chip Ultrasonic Platform for Real-Time and Nondestructive Assessment of Extracellular Matrix Stiffness
Royal Society of Chemistry's Lab on a Chip Journal
Mar 8, 2021
May 13, 2020
Purdue Office of Technology Commercialization
The Convergence Center
101 Foundry Drive, Suite 2500
West Lafayette, IN 47906
Phone: (765) 588-3475
Fax: (765) 463-3486